In particular, the currently observed antitumor efficacy of the novel coumarin derivative VIIb in MCF-7 cells suggests the potential to evolve as a promising anti-cancer compound via dual inhibition of the PI3K/Akt axis. This evidence concerns the gene PIK3CB and cancer.